Nyxoah SA (FRA:5YI)
€ 1.214 -0.012 (-0.98%) Market Cap: 138.50 Mil Enterprise Value: 147.64 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 65/100

Nyxoah SA at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 12:15 AM GMT
Release Date Price: €2.3 (-4.38%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NYXH.BR - Nyxoah SA
Nyxoah SA at Bank of America Global Healthcare Conference
May 14, 2026 / 12:15AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
I'm on the MedTech team here at Bank of America. Really happy to introduce our next presenter, Nixoa. We have CEO, Olivier Telman, to present.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon, everyone. First of all, thank you and thank you, Bank of America, for having us and to be able to explain a little bit and talk a little bit more about the Nixoa story.

When we talk about Nyxola, we are talking about obstructive sleep apnea and the treatment of obstructive sleep apnea by offering a neuromodulation solution. Before I dig in a little bit further into
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot